DANIEL ROSA: Open Payments
NPI 1568592962 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,277 in 34 payments from 11 companies in 2025. Trend: 2023 $189 · 2024 $666 · 2025 $1,277
Food & beverage: $1,277
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 7 | $359 |
| Alkermes, Inc. | 6 | $250 |
| ABBVIE INC. | 8 | $238 |
| Gilead Sciences, Inc. | 1 | $114 |
| EMD Serono, Inc. | 4 | $92 |
| PFIZER INC. | 2 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $59 |
| Exact Sciences Corporation | 1 | $35 |
| Axsome Therapeutics, Inc. | 1 | $31 |
| Hologic Sales and Service, LLC | 1 | $23 |
Products named: CABENUVA, VRAYLAR, LYBALVI, ARISTADA, Yeztugo, PREVNAR 20, CAPLYTA, Cologuard Collection Kit.
Industry payments across NY — which companies pay providers there.
